Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether intensive insulin therapy can improve outcomes in COVID-19 patients with dysglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Benha University | Conditions: COVID-19, Dysglycemia | Phase 1 | Status: COMPLETED